Half-year report · Q2
8095.TEDINET S100WCCI
Period2024-12-01 → 2025-05-31
Filed2025-07-11
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥30.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net sales |
| Revenue | ¥58.0bn | 2023-12-01 → 2024-11-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥28.1bn | 2023-12-01 → 2024-05-31 | Cons. | Net sales |
| Operating income | ¥2.2bn | 2024-12-01 → 2025-05-31 | Cons. | Operating income |
| Operating income | ¥1.3bn | 2023-12-01 → 2024-05-31 | Cons. | Operating income |
| Ordinary income | ¥2.1bn | 2024-12-01 → 2025-05-31 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.4bn | 2023-12-01 → 2024-05-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.0bn | 2024-12-01 → 2025-05-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.1bn | 2023-12-01 → 2024-05-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥704m | 2023-12-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.3bn | 2024-12-01 → 2025-05-31 | Cons. | Profit loss |
| Net income | ¥701m | 2023-12-01 → 2024-05-31 | Cons. | Profit loss |
| Total assets | ¥65.5bn | at 2025-05-31 | Cons. | Assets |
| Total assets | ¥64.6bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥66.5bn | at 2024-05-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥39.5bn | at 2025-05-31 | Cons. | Liabilities |
| Total liabilities | ¥39.3bn | at 2024-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥26.0bn | at 2025-05-31 | Cons. | Net assets |
| Net assets / equity | ¥25.3bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥29.1bn | at 2024-05-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥6.3bn | at 2025-05-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.1bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥6.2bn | at 2025-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.6bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-11-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥1.1bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.8bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥2.3bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥1.6bn | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.9bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥1.5bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | ¥775m | 2024-12-01 → 2025-05-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.7bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.9bn | 2023-12-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥31.97 | 2024-12-01 → 2025-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-63.18 | 2023-12-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.75 | 2023-12-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 39.5% | at 2025-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 43.5% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 62
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-12-01 → 2025-05-31 | ¥25m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-12-01 → 2025-05-31 | ¥17m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-12-01 → 2025-05-31 | −¥202m |
| Reconciling Itemsreconciling | revenue | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-12-01 → 2025-05-31 | −¥529m |
| Reconciling Itemsreconciling | segment profit | 2024-12-01 → 2025-05-31 | ¥139m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥11.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥11.6bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥319m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥871m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥8.1bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥8.0bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥48m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥544m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥4.5bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥1m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥190m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2024-12-01 → 2025-05-31 | ¥6.2bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2024-12-01 → 2025-05-31 | ¥6.0bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥152m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2024-12-01 → 2025-05-31 | ¥679m |
| —segment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| —segment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| —segment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥521m |
| —segment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-05-31 | ¥30.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-05-31 | ¥30.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-12-01 → 2025-05-31 | ¥529m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-05-31 | ¥2.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-12-01 → 2024-05-31 | ¥26m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-12-01 → 2024-05-31 | ¥18m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-12-01 → 2024-05-31 | −¥51m |
| Reconciling Itemsreconciling | revenue | 2023-12-01 → 2024-05-31 | −¥739m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-12-01 → 2024-05-31 | −¥739m |
| Reconciling Itemsreconciling | segment profit | 2023-12-01 → 2024-05-31 | ¥30m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥10.9bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥10.4bn |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥495m |
| jpcrp040300-q2r_E02585-000Fine Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥0 |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥6.8bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥6.7bn |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥60m |
| jpcrp040300-q2r_E02585-000Health And Beauty Care Foodreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥198m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥35m |
| jpcrp040300-q2r_E02585-000Industrial Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥551m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue | 2023-12-01 → 2024-05-31 | ¥5.6bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue external | 2023-12-01 → 2024-05-31 | ¥5.4bn |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥140m |
| jpcrp040300-q2r_E02585-000Medicalreportable segment | segment profit | 2023-12-01 → 2024-05-31 | ¥616m |
| —segment total | revenue | 2023-12-01 → 2024-05-31 | ¥28.8bn |
| —segment total | revenue external | 2023-12-01 → 2024-05-31 | ¥28.1bn |
| —segment total | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥731m |
| —segment total | segment profit | 2023-12-01 → 2024-05-31 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-12-01 → 2024-05-31 | ¥28.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-12-01 → 2024-05-31 | ¥28.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-12-01 → 2024-05-31 | ¥739m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-12-01 → 2024-05-31 | ¥1.3bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 615
| Item | Context | Value | Unit |
|---|---|---|---|
| Cash dividends paid fin cf | CurrentYTDDuration | -367000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -1877000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | 775000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 24000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | -33000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -1130000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 238000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 6758000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 5978000000 | JPY |
| Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation cce | Prior1YTDDuration | -38000000 | JPY |
| Decrease in cash and cash equivalents resulting from exclusion of subsidiaries from consolidation cce | CurrentYTDDuration | － | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 5588000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 6216000000 | JPY |
| Packing and transportation expenses sga | Prior1YTDDuration | 856000000 | JPY |
| Packing and transportation expenses sga | CurrentYTDDuration | 877000000 | JPY |
| Provision of allowance for doubtful accounts sga | Prior1YTDDuration | -1000000 | JPY |
| Provision of allowance for doubtful accounts sga | CurrentYTDDuration | -0 | JPY |
| Compensations salaries and allowances sga | Prior1YTDDuration | 2522000000 | JPY |
| Compensations salaries and allowances sga | CurrentYTDDuration | 2648000000 | JPY |
| Retirement benefit expenses sga | Prior1YTDDuration | 121000000 | JPY |
| Retirement benefit expenses sga | CurrentYTDDuration | 89000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02585-000FineChemicalsReportableSegmentsMember | 10356000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | 6702000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02585-000MedicalReportableSegmentsMember | 5414000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_jpcrp040300-q2r_E02585-000IndustrialChemicalsReportableSegmentsMember | 5599000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReportableSegmentsMember | 28073000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 18000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 28091000000 | JPY |
| Revenues from external customers | Prior1YTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | Prior1YTDDuration | 28091000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02585-000FineChemicalsReportableSegmentsMember | 495000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | 60000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02585-000MedicalReportableSegmentsMember | 140000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_jpcrp040300-q2r_E02585-000IndustrialChemicalsReportableSegmentsMember | 35000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReportableSegmentsMember | 731000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 7000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 739000000 | JPY |
| Transactions with other segments | Prior1YTDDuration_ReconcilingItemsMember | -739000000 | JPY |
| Transactions with other segments | Prior1YTDDuration | － | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02585-000FineChemicalsReportableSegmentsMember | 10851000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | 6762000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02585-000MedicalReportableSegmentsMember | 5555000000 | JPY |
| Net sales | Prior1YTDDuration_jpcrp040300-q2r_E02585-000IndustrialChemicalsReportableSegmentsMember | 5635000000 | JPY |
| Net sales | Prior1YTDDuration_ReportableSegmentsMember | 28805000000 | JPY |
| Net sales | Prior1YTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 26000000 | JPY |
| Net sales | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 28831000000 | JPY |
| Net sales | Prior1YTDDuration_ReconcilingItemsMember | -739000000 | JPY |
| Net sales | Prior1YTDDuration | 28091000000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02585-000FineChemicalsReportableSegmentsMember | -0 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E02585-000HealthAndBeautyCareFoodReportableSegmentsMember | 198000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |